FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, specifically to an ophthalmic moisturizing agent and a method for preparation thereof. Ophthalmic moistener contains sodium hyaluronate, sodium chloride, sodium dihydrophosphate monohydrate, sodium hydrogen phosphate dodecahydrate, polyhexanide and water in following amount in mg per ml: sodium hyaluronate 0.05-5.0, sodium chloride 0.05-20.0, sodium dihydrophosphate monohydrate 0.01-1.0, sodium hydrogen phosphate dodecahydrate 0.01-1.0, polyhexanide 0.01-1.0, water – balance, wherein kinematic viscosity is within, mm2/s: 2.0-5.5. Method of producing said moisturizing agent, characterized by that sodium chloride, sodium dihydrophosphate monohydrate, sodium hydrogen phosphate dodecahydrate are successively dissolved in water, separately dissolving sodium hyaluronate and polyhexanide in water, after which the solutions of sodium salts and sodium hyaluronate are mixed, and then the polyhexanide solution is gradually added to the combined solution while stirring continuously.
EFFECT: using the group of inventions provides preparing the moisturizing agent, as well as prolonging the lachrymal film rupture time when using the above agent, especially if observing the low viscosity of the preparation that enables instilling from 1 drop no more than 1-3 times a day.
2 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC MOISTURIZING SOLUTION | 2019 |
|
RU2706703C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
CONTACT LENS CARE SOLUTION | 2020 |
|
RU2755298C1 |
LATANOPROST-BASED LIQUID MEDICAMENT AND METHOD FOR PREPARING SAME | 2024 |
|
RU2839141C1 |
DIAGNOSTIC TECHNIQUE AND METHOD OF THERAPY OF DRUG-INDUCED DRY EYE SYNDROME | 2014 |
|
RU2554818C1 |
OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING BRANCHED POLYHEXAMETHYLENE GUANIDINES AND POLY(N-VINYLPYRROLIDONE) | 2012 |
|
RU2509562C1 |
METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
MEDICATION FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGICAL DISEASES | 2008 |
|
RU2359658C1 |
OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION AND METHODS OF ITS PREPARATION AND USE | 2019 |
|
RU2812316C2 |
PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTING OR TREATING DRY EYES SYNDROME | 2018 |
|
RU2722485C1 |
Authors
Dates
2025-05-12—Published
2024-10-21—Filed